Startup profile · funding coverage
StandardX funding, valuation and investors
Deep-tech isotope company launched with a £10 million seed round to build a scalable isotope refinery.
Keep track of StandardX
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
£10M · September 23, 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · United Kingdom
Investors in latest funding
Lead: Vsquared Ventures , East X Ventures
Overview
StandardX is building a scalable isotope refinery intended to increase supplies of rare isotopes used in medicine, research and fusion. The company announced its launch and a £10 million seed round on September 23, 2026, led by Vsquared Ventures and East X Ventures.
Why StandardX is interesting
A distinctive deep-tech financing tied to medical isotopes and fusion, with first-party disclosure and a clear seed-stage narrative.
Key facts
- Sep 23, 2026: £10M seed
- Company is building a scalable isotope refinery for medicine and fusion
Funding history (newest first)
Seed
2026-09-23 £10M- Vsquared Ventures (lead)
- East X Ventures (lead)
Market / IPO context
Editorial / static context — not a live quote.
FAQs about StandardX
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.